Benzinga - Thu, 08 Apr 2021 05:01:56 -0400
Benzinga - Wed, 07 Apr 2021 13:04:30 -0400
Benzinga - Wed, 07 Apr 2021 12:51:35 -0400
Benzinga - Wed, 07 Apr 2021 08:12:41 -0400
Benzinga - Wed, 07 Apr 2021 07:12:07 -0400
Benzinga - Wed, 07 Apr 2021 03:11:08 -0400
Benzinga - Tue, 06 Apr 2021 12:33:59 -0400
Benzinga - Tue, 06 Apr 2021 10:58:01 -0400
Benzinga - Wed, 31 Mar 2021 08:15:22 -0400
Benzinga - Wed, 31 Mar 2021 08:14:53 -0400
load more
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-10
REV
Q4 2020Est.ActualSurprise
EPS-0.170-0.130 0.0400
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GALTGalectin Therapeutics-13.36%129.7M

Galectin Therapeutics Company Questions & Answers

Q

How do I buy Galectin Therapeutics (GALT) stock?

A

You can purchase shares of Galectin Therapeutics (NASDAQ: GALT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Galectin Therapeutics's (GALT) main competitors?

A

There are no as such competitors for Galectin Therapeutics.

Q

What is the target price for Galectin Therapeutics?

A

The latest price target for Galectin Therapeutics (NASDAQ: GALT) was reported by HC Wainwright & Co. on 2020-08-13. The analyst firm set a price target for 12.00 expecting GALT to rise to within 12 months (a possible 428.63% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Galectin Therapeutics (GALT) stock ?

A

The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.27 last updated Mon Apr 12 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Galectin Therapeutics (GALT) dividend?

A

There are no upcoming dividends for Galectin Therapeutics.

Q

When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?

A
Galectin Therapeutics’s Q1 earnings are confirmed from now on May 10, 2021.
Q

When is the upcoming split for GALT?

A

There is no upcoming split for Galectin Therapeutics.